Enterprise Value to EBITDA Multiple ratio Analysis of Arcus Biosciences Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-3.60
Period Ending - Dec-22
Very Poor EV to EBITDA
-2.39
Growth
-50.24 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-4.88
EV to EBITDA Analysis of Arcus Biosciences Inc
| EV to EBITDA Ratio of RCUS drastically fell by -50.24 % this year. |
| EV to EBITDA Ratio with value of 12.45 was highest in Year Dec-21 in last Five Years. |
| EV to EBITDA Ratio with value of -7.54 was lowest in Year Dec-19 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -3.60 is lower than Average EV to EBITDA of -1.34 in last five years. |
Other EV to EBITDA Related Info of RCUS that may interest you.
Arcus Biosciences Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| RCUS | 15.07 | 14.93 | 0.938 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Arcus Biosciences Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -3.60 | -2.39 | 12.45 | -5.62 | -7.54 | -9.94 | -5.44 |
| Change | -50.24 % | -119.23 % | 321.37 % | 25.44 % | 24.13 % | -82.64 % | 70.26 % |
FY Chart of Enterprise Value to EBITDA Multiple of Arcus Biosciences Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)